TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Average medical costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: False-negative biopsy results
Endpoint domain: Adverse events/effects
Primary endpoint: Mean BCVA changes at month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean central retinal thickness changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean ranibizumab retreatments during 12 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Scar contracture prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in joint function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Texture of transplanted skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Situational anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tolerability of the procedure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Identification of malignant lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary patency rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incidence of atopic eczema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance at psychosocial treatment intervention sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Successful repletion of vitamin D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to successful repletion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PEF%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ICS doses
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: time to first cardiovascular hospitalization or death
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: peripheral neuropathy
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Compliance with study medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Survival medians
Endpoint domain: Mortality/survival
Primary endpoint: Weight gain of more than 20% of prestudy weight
Endpoint domain: Adverse events/effects
Primary endpoint: Level of confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frustration levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Scores on acquired skills exam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive performance measured by Memory for Objects test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patellar tendon modulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Five repetition maximum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of stroke at 1 year of follow-up
Endpoint domain: Mortality/survival
Primary endpoint: morphine demands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic tenderness at 5 and 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Chronic pelvic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Recurrent pelvic inflammatory disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: endometrial receptivity markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Major bleeding occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: peak oxygen uptake (VO₂ peak)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak power output (Wpeak)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Barthel and Katz ADL scale scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction in sperm disomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Area under the curve (AUC) for pravastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) for simvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) for atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean increase in hemoglobin values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of women reporting amenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of women reporting health problems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in participant-reported pain on palpation of the most painful pelvic floor muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stress-specific continence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression rate
Endpoint domain: Mortality/survival
Primary endpoint: Attention scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: impact on clinical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ninety-day nursing home use
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Pain Disability Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: relative urinary resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: International Prostate Symptom Score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Doppler perfusion index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total blood flow relative to liver volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recall of opportunistic inquiry about cervical screening status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recall of advice about cervical screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recall of written information about cervical screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Readmission to hospital with recurrent fever
Endpoint domain: Adverse events/effects
Primary endpoint: Average cost per episode of fever and neutropenia
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: CPT pain responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speed of wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rates of diffuse gastric cancer
Endpoint domain: Mortality/survival
Primary endpoint: Need for mechanical ventilation (MV) in the first 5 days of life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total daily inhaled corticosteroids (ICS) dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent sliding hiatal hernia
Endpoint domain: Adverse events/effects
Primary endpoint: Emergency hospital admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of chlamydia screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activation of coagulation (thrombin-antithrombin complex)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Red blood cell damage (free Hb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Healing of genital ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean body weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-surgical morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Serum levels of IL-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evolution of EE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of OD/death
Endpoint domain: Mortality/survival
Primary endpoint: HBsAb levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Opioid craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost-effectiveness of treatment options
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in death or severe disability
Endpoint domain: Mortality/survival
Primary endpoint: Incremental cost per life year gained
Endpoint domain: Resource use
Primary endpoint: Incremental cost per disability-free life year gained
Endpoint domain: Resource use
Primary endpoint: Microvascular filtration coefficient (Kf) in the calf
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Upright leg venous pressure (Pv)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Calf blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: time to urination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: home discharge time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of suicidal ideation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Average Adjusted Symptom Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants' global evaluation of treatment success
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: All-cause mortality at 18 months
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative pregnancy rate (CPR)
Endpoint domain: Life impact
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Cumulative probability of first pregnancy
Endpoint domain: Life impact
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Muscle activation patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: recurrence of AF/AFL or ACM
Endpoint domain: Mortality/survival
Primary endpoint: number of joints smoked per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in the number of joints smoked
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: medial and lateral tibial cartilage volume loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: cartilage defect score increment in the medial tibiofemoral compartment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Decrease in GO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to complete re-epithelialization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: healing of keratitis by day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCtau
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: C(min)ss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C(av)ss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in-room activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sound levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FE of hepcidin‐25
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Diagnostic accuracy of imaging methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BIS value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma beta-EP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction degree
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of Life (QOL) related to Nasal Symptoms (NS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Direct medical in-hospital costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Costs related to absence from work
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Decrease of 18F‐fluoro‐L‐DOPA uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of T‐lymphocyte apoptosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: FasL gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in arm flexor muscular strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in upper arm muscle area (UAMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in fat-free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excretion of pyridinoline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Excretion of deoxypyridinoline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sustained clinically significant worsening of FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: SGRQ score change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median melanoma-specific survival
Endpoint domain: Mortality/survival
Primary endpoint: absolute CVD risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Long-term virological improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term biochemical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term serological improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term histological improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in surface area covered by telangiectasias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in vessel diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in background erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Obesity prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hypercholesterolemia prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hypertriglyceridemia prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: transection speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: β-stiffness improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sustained positive changes in attitudes and behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rmin,rs (airway resistance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rmax,rs (airway resistance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PEEPi,st (airway pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients with scheduled outpatient appointments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients making scheduled visits in the outpatient clinic
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Ovulation inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of unscheduled bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: SEPP1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analgesia measured by visual analog scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean popliteal artery flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rate of anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Full compliance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in cGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: incidence of obstruction
Endpoint domain: Adverse events/effects
Primary endpoint: Adherence to Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total postoperative morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: breathlessness improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk for LGA newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetic fetopathia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma tHcy concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average difference between in situ measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cohen's Kappa on detection of ≥20 mm polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-6 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean MiniAQLQ scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement on the 17-item Hamilton Depression Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feeding performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QTcF interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Dosage of anesthetics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Initiation and completion of physical activity intervention programme
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SOFAS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of psychiatric admissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: cell proliferation in the sigmoid colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: combined stroke and death rate
Endpoint domain: Mortality/survival
Primary endpoint: disabling nonfatal strokes
Endpoint domain: Adverse events/effects
Primary endpoint: Mean pain score using the Visual Analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Collagen and elastic fibers increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of decrease of melanin content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Bone Ultrasound Assessment (BUA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximal vertical jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Estimated maximal oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Interference with activities of daily living (ADLs)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Provider satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Inspiratory resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ventilation requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dynamic intrinsic positive end-expiratory pressure (PEEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pre-sleep salivary cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diurnal urinary cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vein Graft Failure (VGF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of developing diabetes
Endpoint domain: Mortality/survival